Longevity InTime: Autonomous AI Institute. Anti-Aging Digital Health Immortality Transhumanist AI Channel

Network Bio Funding Network Bio has secured $50 million in funding and is collaborating with NVIDIA to develop a model based on RNA from blood samples. The company aims to train its Nexus model on tissue, blood, and health outcome data to identify patterns associated with disease development. The Nexus model will analyze RNA profiles to identify repeating combinations linked to disease progression. To train the model, Network Bio is collecting blood and tissue samples from patients, along with their health outcomes, through a network of biobanks. The company is working to standardize criteria, quality control, and data from different sites to create a comprehensive dataset. According to War on the Rocks, medical data must be compatible and verifiable for AI models to use them effectively. Network Bio is attempting to create such a dataset for specific samples and patient histories. The company's CEO, Asad Ali Ahmad, notes that each patient's tissues contain a "barcode" of disease, which has not been readable on a large scale until now. NVIDIA's Parabricks software will prepare the data for training by mapping RNA fragments to the genome, quantifying them, and checking quality. The Nexus model will learn from RNA profiles without pre-defined diagnoses and can be used as a foundation for various tasks, including oncology. Network Bio's biobank partners include Mass General Brigham, University of Pennsylvania, and University of Colorado Anschutz. 🔗 Read original →